Lihe Biomedical Technology Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 2

Lihe Biomedical Technology General Information

Description

Developer of biosynthesis and green chemical technology intended for biomedicine. The company develops biomedicine in a sustainable way that replaces traditional chemical production processes with biosynthesis and green chemical technology, greatly accelerating green manufacturing and improving production efficiency by reducing the use of flammable, explosive and toxic drugs and the emissions of chemical wastes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Room E302, E306, 5th Floor, Building B8, Bio-Industry (Jiufeng) Innovation Base
  • No. 666 Gaoxin Avenue, East Lake New Technology Development Zone
  • Wuhan, Hubei
  • China
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lihe Biomedical Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 30-Jun-2018 Completed Generating Revenue
To view Lihe Biomedical Technology’s complete valuation and funding history, request access »

Lihe Biomedical Technology Executive Team (1)

Name Title Board Seat Contact Info
Fan Peng Chief Executive Officer & Founder
To view Lihe Biomedical Technology’s complete executive team members history, request access »

Lihe Biomedical Technology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Donghu Venture Capital Venture Capital Minority 000 0000 000000 0
Wuhan Optics Valley Elite Investment Management Venture Capital Minority 000 0000 000000 0
To view Lihe Biomedical Technology’s complete investors history, request access »